HITK Related Analyst Ratings

Mar 14, 2013 10:51 AM Standpoint Research Upgrades Hi Tech Pharmacal (HITK) to Buy

Dec 7, 2012 12:54 PM Q2 Results Remove Uncertainty in Hi Tech Pharmacal (HITK)

Nov 30, 2012 09:35 AM Standpoint Research Downgrades Hi Tech Pharmacal (HITK) to Hold

Aug 15, 2012 09:25 AM Canaccord Genuity Reiterates a 'Buy' on Hi Tech Pharmacal (HITK); Highlights From Meeting with CEO/CFO

Jul 25, 2012 08:43 AM CRT Capital Upgrades Hi Tech Pharmacal (HITK) to Buy

Jul 11, 2012 08:40 AM Needham & Company on Hi Tech Pharmacal (HITK): Four Reason to Buy the Stock Here

Jul 11, 2012 08:22 AM Needham & Company Maintains a 'Hold' on Hi Tech Pharmacal (HITK); Q4 Mixed; Flonase Beginning To Show Its Age

Jul 3, 2012 08:44 AM Canaccord Genuity Maintains a 'Buy' on Hi Tech Pharmacal (HITK); Accumulate on Pullback

Jun 11, 2012 08:51 AM Canaccord Genuity Maintains a 'Buy' on Hi Tech Pharmacal (HITK); Bumpy Q4 Could Double As Inflection Point

May 7, 2012 10:30 AM Standpoint Research Starts Hi Tech Pharmacal (HITK) at Buy; Large Pipeline

Mar 9, 2012 10:09 AM Canaccord Genuity Maintains a 'Buy' on Hi Tech Pharmacal (HITK); Updating Model

Mar 9, 2012 07:49 AM Needham & Company Maintains a 'Hold' on Hi Tech Pharmacal (HITK); Upside Momentum Stalls Out In 3Q

Mar 6, 2012 08:27 AM Canaccord Genuity Maintains a 'Buy' on Hi Tech Pharmacal (HITK); Lowering FQ3 on Softer Anticipated Cough and Cold Season

Feb 1, 2012 10:09 AM Canaccord Genuity Maintains a 'Buy' on Hi Tech Pharmacal (HITK); Positive After Meeting with Mgmt

Jan 11, 2012 08:49 AM Canaccord Genuity Reiterates a 'Buy' on Hi Tech Pharmacal (HITK) on Sell-off Post Checks, Management Meeting

Jan 5, 2012 11:01 AM Canaccord Genuity on Life Sciences/Specialty Pharmaceuticals: Three Small-Cap Buy Ideas for 2012

Jan 5, 2012 08:18 AM Canaccord Genuity Starts Hi Tech Pharmacal (HITK) at Buy; Well Positioned High-Barrier Platform with Strategic Value

Dec 5, 2011 02:49 PM Hi-Tech Pharmacal (HITK) Shares Dip Midday Following Needham Downgrade

Sep 8, 2011 07:31 AM Needham & Company Maintains a 'Buy' on Hi Tech Pharmacal (HITK); Positive Sense of Déjà Vu as Generic Flonase Drives 1QFY12 Results

Apr 8, 2011 07:41 AM Needham & Company Maintains a 'Buy' on Hi Tech Pharmacal (HITK); Keeps The Approval Hitting Streak Alive With Another Infield Single

Mar 3, 2011 07:40 AM Needham & Company Maintains a 'Buy' on Hi Tech Pharmacal (HITK); Sell-Off Overdone

Feb 23, 2011 08:34 AM Needham & Company Maintains a 'Buy' on Hi Tech Pharmacal (HITK); Positive Surprise as Previously Undisclosed Product is Unveiled

Feb 11, 2011 08:28 AM Needham & Company Maintains a 'Buy' on Hi Tech Pharmacal (HITK); FDA Warning Letter Issues Appear in Rearview Mirror as FDA Grants Final Approval to Quixin ANDA

Jul 14, 2010 08:03 AM Needham & Company Maintains a 'Buy' on Hi Tech Pharmacal (HITK); Accumulate on Weakness - Growth Story Intact With Compelling Valuation

Jul 2, 2010 08:17 AM Needham & Company Maintains a 'Buy' on Hi Tech Pharmacal (HITK); Weakness Related to FDA Event a Buying Opportunity

May 19, 2010 07:53 AM Needham & Company Initiates Coverage on Hi Tech Pharmacal (HITK) with a Buy; Revenue Momentum Remains Strong

Dec 23, 2009 09:34 AM Bank of America Initiates Coverage on Hi-Tech Pharmacal (HITK) with an Underperform

Sep 10, 2009 11:30 AM FTN Equity Downgrades Hi-Tech Pharmacal (HITK) from Buy

Jan 17, 2008 09:16 AM FTN Midwest Upgrades Hi-Tech Pharmacal (HITK) to Buy

Jun 28, 2006 10:55 AM Matrix upgrades Hi Tech Pharmacal (HITK) to Hold

Jun 6, 2006 09:56 AM FTN Midwest Starts Hi Tech Pharmacal (HITK) at Buy